The association of air pollutants and allergic and nonallergic rhinitis in chronic rhinosinusitis

Background There has been little investigation regarding air quality and rhinitis in the pathophysiology of upper airway disease. In this study, we assessed the impact of inhalant pollutants (particulate matter 2.5 [PM2.5] and black carbon [BC]) on allergic rhinitis and chronic rhinosinusitis (CRS)...

Full description

Saved in:
Bibliographic Details
Published inInternational forum of allergy & rhinology Vol. 8; no. 3; pp. 369 - 376
Main Authors Mady, Leila J., Schwarzbach, Hannah L., Moore, John A., Boudreau, Robert M., Kaffenberger, Thomas M., Willson, Thomas J., Lee, Stella E.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.03.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background There has been little investigation regarding air quality and rhinitis in the pathophysiology of upper airway disease. In this study, we assessed the impact of inhalant pollutants (particulate matter 2.5 [PM2.5] and black carbon [BC]) on allergic rhinitis and chronic rhinosinusitis (CRS) disease severity. Methods CRS patients with nasal polyps (CRSwNP) and without polyps (CRSsNP) were identified. Spatial modeling from pollutant monitoring sites was used to estimate exposures for patients meeting the inclusion criteria (total, n = 125; CRSsNP, n = 67; CRSsNP, n = 58). Skin‐prick, intradermal dilutional, and in‐vitro testing methods were utilized to determine aeroallergen sensitization. Disease severity indicators were measured by modified Lund‐Mackay score (LMS), the 22‐item Sino‐Nasal Outcome Test (SNOT‐22), systemic steroid therapy, and number of functional endoscopic sinus surgeries (FESS). Results Thirty‐six percent (n = 45) of patients who described rhinitis symptoms demonstrated no reactivity to aeroallergen testing. Sixty‐four percent (n = 80) tested positive for at least 1 allergen, with no differences found between CRSsNP and CRSwNP (62.1% vs 67.2%). There were significant differences in air pollutants between patients testing negative and positive for allergies (nonallergic vs allergic: PM2.5, 11.32 vs 11.07 μg/m3, p = 0.030; BC, 0.81 vs 0.76 absorbance, p =0.044). Nonallergic CRSwNP demonstrated higher PM2.5 compared with allergic counterparts (11.48 vs 11.09 μg/m3, p = 0.032). A similar pattern was observed with BC (0.82 vs 0.75 absorbance, p = 0.017). In CRSsNP, BC correlated significantly with SNOT‐22 (r = 0.55, p = 0.042). Conclusion Our results suggest that small inhalant pollutants may contribute to nonallergic symptomatology in patients with and without nasal polyps. Regardless of allergy status, BC may play a role in CRS symptom severity.
Bibliography:Presented at the AAOA Annual Scientific Meeting, on September 10, 2017, in Chicago, IL.
This work was awarded first place by the AAOA Board of Directors at the 2017 Annual Meeting.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2042-6976
2042-6984
DOI:10.1002/alr.22060